Month: August 2020

Ashvattha Therapeutics Subsidiary Orpheris Enrolls First Patients in Phase 2 PRANA Clinical Study Evaluating OP-101 for Severe COVID-19

November 12, 2020August 31, 2020 by ashvatthaadmin

Orpheris, a subsidiary of Ashvattha, announced enrollment of the first patients in its multicenter Phase 2 PRANA clinical study of the HDT, OP-101, to treat hospitalized adults with severe COVID-19.

Categories Press Release

Search for:

Howdy, this is Creativo

We just added a brand new Off Canvas Sidebar. You can change the content you see here by going to Appearance -> Widgets -> Off Canvas Sidebar.

Of course you can also change the design of this sidebar by going to Appearance -> Theme Options -> Off Canvas Sidebar.

Change everything from: background color, font color, font size, sidebar headings and more.